Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés.
View in English
Entrega niosómica de imatinib a base de ciclodextrina contra las células de cáncer de pulmón de células no pequeñas A549
- Hay Marn Hnin 1, Theingi Tun 1, Chaisak Chansriniyom 2,3, Natsaranyatron Singharajkomron 4,5, Varisa Pongrakhananon 4,6, Thorsteinn Loftsson 7, Phatsawee Jansook 1,8
- Hay Marn Hnin 1, Theingi Tun 1, Chaisak Chansriniyom 2,3
- 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
- 2Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
- 3Center of Excellence in Natural Products and Nanoparticles, Chulalongkorn University, Bangkok 10330, Thailand.
- 4Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
- 5Department of Research and Development, Provenedge Co., Ltd., Bangkok 10330, Thailand.
- 6Preclinical Toxicity and Efficacy Assessment of Medicines and Chemicals Research Unit, Chulalongkorn University, Bangkok 10330, Thailand.
- 7Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik IS-107, Iceland.
- 8Cyclodextrin Application and Nanotechnology-based Delivery Systems Research Unit, Chulalongkorn University, Bangkok 10330, Thailand.
- 0Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.
Videos de Experimentos Relacionados
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Videos de Experimentos Relacionados
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.

